SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...

Artificial intelligence leader Nvidia Corp. Monday announced the Nemotron-3 family of models, data and tools, and the release is further evidence of the company’s commitment to the open ecosystem, ...

The Allen Institute for AI (Ai2) hopes to take advantage of an increased demand for customized models and enterprises seeking more transparency from AI models with its latest release. Ai2 made the ...

FDA clearance received to start the pivotal, 500-patient, placebo-controlled Phase 3 “PREVAiLS” study of pridopidine in participants with early, rapidly progressive ALS; US recruitment set to begin ...